Web Desc
Viral Immunity
Organizer(s): Jack R. Bennink, Marcia A. Blackman and Ann B. Hill
Date: January 20 - 25, 2008
Location: Keystone Resort, Keystone, CO, USA
Supported by the Director's Fund
Summary of Meeting:
The most exciting recent advances in viral immunity include the increased understanding of the role of innate immune mechanisms, interaction between innate and adaptive immunity, pathogen manipulation of host responses, and activation of immune responses and generation of immune memory. Despite these advances, basic mechanisms of anti-viral immunity are poorly characterized for many acute infections and less well understood for chronic infections. Efforts are also required to exploit recent research advances to improve vaccine design and therapeutic intervention. This meeting will include both innate and adaptive immunity and juxtapose animal models with human studies as it attempts to foster collaborative efforts between attending viral immunologists. Expert talks in plenary sessions will encompass the latest in critical areas of viral immunity. Workshops and additional presentations will cover provocative and cutting-edge results from attendees. The meeting objective is to accelerate progress in understanding and manipulating anti-viral immunity to improve human health.
Scholarship Deadline: September 20 2007
Discounted Abstract Deadline: September 20 2007
Abstract Deadline: October 23 2007
Discounted Registration Deadline: November 20 2007
We gratefully acknowledge additional support for this conference from:
Burroughs Wellcome Fund
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI075653-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Sunday, January 20 | 3:00PM - 7:30PM
Registration
Room: Shavano Peak Foyer


Sunday, January 20 | 6:30PM - 7:30PM
Refreshments
Room: Shavano Peak Foyer


Sunday, January 20 | 7:30PM - 7:45PM
Welcome and Opening Remarks
Room: Shavano/Torreys

Speaker 1 of 3
* Jack R. Bennink, NIAID, National Institutes of Health, USA

Sunday, January 20 | 7:30PM - 7:45PM
Welcome and Opening Remarks
Room: Shavano/Torreys

Speaker 2 of 3
* Marcia A. Blackman, Trudeau Institute, USA

Sunday, January 20 | 7:30PM - 7:45PM
Welcome and Opening Remarks
Room: Shavano/Torreys

Speaker 3 of 3
* Ann B. Hill, Oregon Health & Science University, USA

Sunday, January 20 | 7:45PM - 8:30PM
Keynote Address
Room: Shavano/Torreys

Speaker 1 of 1
Gary J. Nabel, Sanofi, USA
Rational Vaccine Design: Where We Are and What We Still Need to Know

Monday, January 21 | 7:00AM - 8:00AM
Breakfast
Room: Crestone/Red Cloud


Monday, January 21 | 8:00AM - 11:15AM
Innate Immunity to Viruses
Room: Shavano/Torreys

Speaker 1 of 7
* Raymond M. Welsh, University of Massachusetts Medical School, USA

Monday, January 21 | 8:00AM - 11:15AM
Innate Immunity to Viruses
Room: Shavano/Torreys

Speaker 2 of 7
Herbert (Skip) W. Virgin, Vir Biotechnology, USA
Regulation of Herpesvirus Latency by Niche-Specific Viral and Host Genes: The Good News about Herpes

Monday, January 21 | 8:00AM - 11:15AM
Innate Immunity to Viruses
Room: Shavano/Torreys

Speaker 3 of 7
Bryan R. Cullen, Duke University Medical Center, USA
Viruses, microRNAs and RNA Interference

Monday, January 21 | 8:00AM - 11:15AM
Innate Immunity to Viruses
Room: Shavano/Torreys

Speaker 4 of 7
Evelyn A. Kurt-Jones, University of Massachusetts Medical School, USA
Toll Like Receptors in Viral Immunity

Monday, January 21 | 8:00AM - 11:15AM
Innate Immunity to Viruses
Room: Shavano/Torreys

Speaker 5 of 7
Mariapia A. Degli-Esposti, LEI, University of Western Australia, Australia
NK Licensing of DCs for Initiation of Adaptive Immunity to Murine Cytomegalovirus

Monday, January 21 | 8:00AM - 11:15AM
Innate Immunity to Viruses
Room: Shavano/Torreys

Speaker 6 of 7
Nicole Baumgarth, University of California, Davis, USA
Short Talk: Infection-Induced Innate Signals Promote Rapid Effector B Cell Responses to Influenza

Monday, January 21 | 8:00AM - 11:15AM
Innate Immunity to Viruses
Room: Shavano/Torreys

Speaker 7 of 7
Deborah J. Lenschow, Washington University School of Medicine, USA
Short Talk: Protein Conjugation is Critical to the Antiviral Activity of ISG15

Monday, January 21 | 9:20AM - 9:40AM
Coffee Break
Room: Shavano Peak Foyer


Monday, January 21 | 11:15AM - 1:00PM
Poster Setup
Room: Crestone/Red Cloud


Monday, January 21 | 1:00PM - 10:00PM
Poster Viewing
Room: Crestone/Red Cloud


Monday, January 21 | 4:30PM - 5:00PM
Coffee Available
Room: Shavano Peak Foyer


Monday, January 21 | 5:00PM - 7:00PM
Cellular and Humoral Effector Mechanisms
Room: Shavano/Torreys

Speaker 1 of 5
* Marcia A. Blackman, Trudeau Institute, USA

Monday, January 21 | 5:00PM - 7:00PM
Cellular and Humoral Effector Mechanisms
Room: Shavano/Torreys

Speaker 2 of 5
Jenny M. Woof, University of Dundee, UK
Anti-Viral Mucosal Immunoglobulins

Monday, January 21 | 5:00PM - 7:00PM
Cellular and Humoral Effector Mechanisms
Room: Shavano/Torreys

Speaker 3 of 5
Ted C. Pierson, NIAID, National Institutes of Health, USA
The Stoichiometry of Antibody-Mediated Neutralization of West Nile Virus: Implications for Vaccine Development and Immune Escape

Monday, January 21 | 5:00PM - 7:00PM
Cellular and Humoral Effector Mechanisms
Room: Shavano/Torreys

Speaker 4 of 5
Mark K. Slifka, Oregon National Primate Research Center, Oregon Health & Science University, USA
Duration of Antiviral T Cell and B Cell Responses and How Monkeypox Seeks to Evade Them


Monday, January 21 | 5:00PM - 7:00PM
Cellular and Humoral Effector Mechanisms
Room: Shavano/Torreys

Speaker 5 of 5
Shane Crotty, La Jolla Institute for Immunology, USA
Short Talk: Selective CD4 T Cell Help for Antibody Responses to Vaccinia, a Large Viral Pathogen: Deterministic Linkage of T and Ab Specificities

Monday, January 21 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Crestone/Red Cloud


Monday, January 21 | 7:30PM - 10:00PM
Poster Session 1
Room: Crestone/Red Cloud


Tuesday, January 22 | 7:00AM - 8:00AM
Breakfast
Room: Crestone/Red Cloud


Tuesday, January 22 | 8:00AM - 11:15AM
Antigen Presentation and Lymphocyte Activation
Room: Shavano/Torreys

Speaker 1 of 7
* David L. Woodland, Keystone Symposia on Molecular and Cellular Biology, USA

Tuesday, January 22 | 8:00AM - 11:15AM
Antigen Presentation and Lymphocyte Activation
Room: Shavano/Torreys

Speaker 2 of 7
Jonathan W. Yewdell, NIAID, National Institutes of Health, USA
Intravital Imaging of Anti-Viral CD8+ T Cell Activation

Tuesday, January 22 | 8:00AM - 11:15AM
Antigen Presentation and Lymphocyte Activation
Room: Shavano/Torreys

Speaker 3 of 7
Francis R. Carbone, University of Melbourne, Australia
Dendritic Cell Subset Involvement during Peripheral Infection

Tuesday, January 22 | 8:00AM - 11:15AM
Antigen Presentation and Lymphocyte Activation
Room: Shavano/Torreys

Speaker 4 of 7
Laurence C. Eisenlohr, Children's Hospital of Philadelphia and University of Pennsylvania, USA
The Many Paths to MHC Class II-Restricted Presentation of the Influenza Glycoproteins

Tuesday, January 22 | 8:00AM - 11:15AM
Antigen Presentation and Lymphocyte Activation
Room: Shavano/Torreys

Speaker 5 of 7
Stephen J. Turner, Monash University, Australia
Acquiring the Capacity to Kill: Molecular Characterisation of Virus-Specific T Cell Function

Tuesday, January 22 | 8:00AM - 11:15AM
Antigen Presentation and Lymphocyte Activation
Room: Shavano/Torreys

Speaker 6 of 7
Chris C. Norbury, Pennsylvania State University Medical School, USA
Short Talk: Viral Sequestration of Antigen Subverts Cross Priming

Tuesday, January 22 | 8:00AM - 11:15AM
Antigen Presentation and Lymphocyte Activation
Room: Shavano/Torreys

Speaker 7 of 7
Gabrielle T. Belz, Walter and Eliza Hall Institute of Medical Research, Australia
Short Talk: Killer T Cell Response to Influenza: Disparate Dendritic Cell Stimulation of Naïve and Memory Cells

Tuesday, January 22 | 9:20AM - 9:40AM
Coffee Break
Room: Shavano Peak Foyer


Tuesday, January 22 | 11:15AM - 12:15PM
Round Table Discussion on Mouse Norovirus and its Impact on
Mouse Colonies and Immunological Studies: How Much Should We Worry?
Room: Shavano/Torreys

Speaker 1 of 4
* Ann B. Hill, Oregon Health & Science University, USA

Tuesday, January 22 | 11:15AM - 12:15PM
Round Table Discussion on Mouse Norovirus and its Impact on
Mouse Colonies and Immunological Studies: How Much Should We Worry?
Room: Shavano/Torreys

Speaker 2 of 4
Herbert (Skip) W. Virgin, Vir Biotechnology, USA

Tuesday, January 22 | 11:15AM - 12:15PM
Round Table Discussion on Mouse Norovirus and its Impact on
Mouse Colonies and Immunological Studies: How Much Should We Worry?
Room: Shavano/Torreys

Speaker 3 of 4
Janko Nikolich-Zugich, University of Arizona College of Medicine, USA

Tuesday, January 22 | 11:15AM - 12:15PM
Round Table Discussion on Mouse Norovirus and its Impact on
Mouse Colonies and Immunological Studies: How Much Should We Worry?
Room: Shavano/Torreys

Speaker 4 of 4
Kim Y. Green, NIAID, National Institutes of Health, USA

Tuesday, January 22 | 11:15AM - 1:00PM
Poster Setup
Room: Crestone/Red Cloud


Tuesday, January 22 | 1:00PM - 10:00PM
Poster Viewing
Room: Crestone/Red Cloud


Tuesday, January 22 | 2:30PM - 4:30PM
Workshop 1: Basic Studies of Innate and Adaptive Immunity
Room: Shavano/Torreys

Speaker 1 of 2
* Barry T. Rouse, University of Tennessee, USA

Tuesday, January 22 | 2:30PM - 4:30PM
Workshop 1: Basic Studies of Innate and Adaptive Immunity
Room: Shavano/Torreys

Speaker 2 of 2
* Aron E. Lukacher, Penn State University College of Medicine, USA

Tuesday, January 22 | 2:30PM - 3:30PM
1A: Innate Immunity
Room: Shavano/Torreys

Speaker 1 of 4
Catherine Ptaschinski, University of Michigan, USA
TLR9 Stimulation Modulates Gammaherpesvirus Latency

Tuesday, January 22 | 2:30PM - 3:30PM
1A: Innate Immunity
Room: Shavano/Torreys

Speaker 2 of 4
Teresa R. Johnson, Edward Via College of Osteopathic Medicine, USA
Respiratory Syncytial Virus (RSV) Infects and Matures Primary Dendritic Cells and DC-Sign/R Binds RSV Attachment Glycoprotein but is not Required for Infection

Tuesday, January 22 | 2:30PM - 3:30PM
1A: Innate Immunity
Room: Shavano/Torreys

Speaker 3 of 4
Lauren A. O'Donnell, Duquesne University, USA
Interferon-Gamma Signaling in Neurons: Classical Pathways or New Roads to Viral Clearance?

Tuesday, January 22 | 2:30PM - 3:30PM
1A: Innate Immunity
Room: Shavano/Torreys

Speaker 4 of 4
Julie McAuley, University of Melbourne, Australia
The 1918 Influenza A Virus PB1-F2 Protein Contributes to the Immunopathogenesis of Viral and Secondary Bacterial Pneumonia

Tuesday, January 22 | 3:30PM - 4:30PM
1B: Cellular and Humoral Effector Mechanisms
Room: Shavano/Torreys

Speaker 1 of 4
Youn Soo Choi, Seoul National University College of Medicine, South Korea
Mechanisms of B-1 Cell Activation to Influenza virus Infection

Tuesday, January 22 | 3:30PM - 4:30PM
1B: Cellular and Humoral Effector Mechanisms
Room: Shavano/Torreys

Speaker 2 of 4
Ryan A. Langlois, University of Minnesota, USA
Regulation of Acute Influenza Virus Immunity by Lymph Node Dendritic Cells

Tuesday, January 22 | 3:30PM - 4:30PM
1B: Cellular and Humoral Effector Mechanisms
Room: Shavano/Torreys

Speaker 3 of 4
Daniela Anghelina, New York University, USA
Critical Role for Regulatory T Cells in Preventing Fatal Disease in Mice with Coronavirus-Induced Encephalitis

Tuesday, January 22 | 3:30PM - 4:30PM
1B: Cellular and Humoral Effector Mechanisms
Room: Shavano/Torreys

Speaker 4 of 4
Magdalini Moutaftsi, Infectious Disease Research Institute, USA
Correlates of Protection Efficacy Induced by VACV-specific CD8+ T cell Epitopes in the Murine Intranasal Challenge Model

Tuesday, January 22 | 4:30PM - 5:00PM
Coffee Available
Room: Shavano Peak Foyer


Tuesday, January 22 | 5:00PM - 7:00PM
Viral Immune Modulators
Room: Shavano/Torreys

Speaker 1 of 5
* Jonathan W. Yewdell, NIAID, National Institutes of Health, USA

Tuesday, January 22 | 5:00PM - 7:00PM
Viral Immune Modulators
Room: Shavano/Torreys

Speaker 2 of 5
Ann B. Hill, Oregon Health & Science University, USA
CMV and the Mammalian Immune System: 70 Million Years of Obsession and Deception

Tuesday, January 22 | 5:00PM - 7:00PM
Viral Immune Modulators
Room: Shavano/Torreys

Speaker 3 of 5
Klaus Früh, Oregon Health & Science University, USA
Novel Host Targets and Functions of Viral and Cellular Membrane Associated RING-CH (MARCH) Proteins

Tuesday, January 22 | 5:00PM - 7:00PM
Viral Immune Modulators
Room: Shavano/Torreys

Speaker 4 of 5
Grant McFadden, University of Florida, USA
Molecular Mechanisms of Poxvirus Immune Evasion and Tropism

Tuesday, January 22 | 5:00PM - 7:00PM
Viral Immune Modulators
Room: Shavano/Torreys

Speaker 5 of 5
Luis J. Sigal, Fox Chase Cancer Center, USA
Short Talk: The Poxvirus IFN-Alpha Binding Protein is Essential for Virulence and an Effective Target for Vaccination

Tuesday, January 22 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Crestone/Red Cloud


Tuesday, January 22 | 7:30PM - 10:00PM
Poster Session 2
Room: Crestone/Red Cloud


Wednesday, January 23 | 7:00AM - 8:00AM
Breakfast
Room: Crestone/Red Cloud


Wednesday, January 23 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infection
Room: Shavano/Torreys

Speaker 1 of 7
* Ann B. Hill, Oregon Health & Science University, USA

Wednesday, January 23 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infection
Room: Shavano/Torreys

Speaker 2 of 7
Marcia A. Blackman, Trudeau Institute, USA
Establishment and Immune Control of gamma-Herpesvirus Latency

Wednesday, January 23 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infection
Room: Shavano/Torreys

Speaker 3 of 7
Christian Münz, University of Zurich, Switzerland
Human Natural Killer Cell Activation by Dendritic Cells during Viral Infection

Wednesday, January 23 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infection
Room: Shavano/Torreys

Speaker 4 of 7
Barbara Rehermann, NIDDK, National Institutes of Health, USA
Host Factors Involved in the Control of Viral Infections

Wednesday, January 23 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infection
Room: Shavano/Torreys

Speaker 5 of 7
Kim J. Hasenkrug, NIAID, National Institutes of Health, USA
Immunotherapy for Chronic Viral Infection

Wednesday, January 23 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infection
Room: Shavano/Torreys

Speaker 6 of 7
Mary Premenko-Lanier, Emory University, USA
Short Talk: Transient FTY720 Treatment Promotes Immune Mediated Clearance of Chronic LCMV

Wednesday, January 23 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infection
Room: Shavano/Torreys

Speaker 7 of 7
Annette Oxenius, Institute for Microbiology, ETH Zürich, Switzerland
Short Talk: CD8+ T Cell Dysfunction During Chronic Viral Infections

Wednesday, January 23 | 9:20AM - 9:40AM
Coffee Break
Room: Shavano Peak Foyer


Wednesday, January 23 | 11:15AM - 1:00PM
Poster Setup
Room: Crestone/Red Cloud


Wednesday, January 23 | 1:00PM - 10:00PM
Poster Viewing
Room: Crestone/Red Cloud


Wednesday, January 23 | 4:30PM - 5:00PM
Coffee Available
Room: Shavano Peak Foyer


Wednesday, January 23 | 5:00PM - 7:00PM
Inflammation, Immune Pathogenesis and Autoimmunity
Room: Shavano/Torreys

Speaker 1 of 5
* Herbert (Skip) W. Virgin, Vir Biotechnology, USA

Wednesday, January 23 | 5:00PM - 7:00PM
Inflammation, Immune Pathogenesis and Autoimmunity
Room: Shavano/Torreys

Speaker 2 of 5
Anne B. Krug, Ludwig Maximilians University Munich, Germany
Activation of TLR-Dependent and TLR-Independent Signaling Pathways by Viral Nucleic Acids

Wednesday, January 23 | 5:00PM - 7:00PM
Inflammation, Immune Pathogenesis and Autoimmunity
Room: Shavano/Torreys

Speaker 3 of 5
Stephen D. Miller, Northwestern University Medical School, USA
Virus-Induced CNS Autoimmunity: Lessons from Theiler's Virus Infection

Wednesday, January 23 | 5:00PM - 7:00PM
Inflammation, Immune Pathogenesis and Autoimmunity
Room: Shavano/Torreys

Speaker 4 of 5
Matthias G. von Herrath, Novo Nordisk and La Jolla Institute for Allergy and Immunology, USA
Novel Avenues for the Immunotherapy of Persistent Viral Infections

Wednesday, January 23 | 5:00PM - 7:00PM
Inflammation, Immune Pathogenesis and Autoimmunity
Room: Shavano/Torreys

Speaker 5 of 5
David M. White, NCID/DVRD/Special Pathogens Branch, USA
Short Talk: Regulatory T-cell Responses to Lassa Fever Virus and Ebolavirus Infection of Dendritic Cells

Wednesday, January 23 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Crestone/Red Cloud


Wednesday, January 23 | 7:30PM - 10:00PM
Poster Session 3
Room: Crestone/Red Cloud


Thursday, January 24 | 7:00AM - 8:00AM
Breakfast
Room: Crestone/Red Cloud


Thursday, January 24 | 8:00AM - 11:15AM
T Cell Memory
Room: Shavano/Torreys

Speaker 1 of 7
* John T. Harty, University of Iowa, USA

Thursday, January 24 | 8:00AM - 11:15AM
T Cell Memory
Room: Shavano/Torreys

Speaker 2 of 7
David L. Woodland, Keystone Symposia on Molecular and Cellular Biology, USA
Regulation of the CD8+ T Cell Recall Response to Respiratory Virus Infections

Thursday, January 24 | 8:00AM - 11:15AM
T Cell Memory
Room: Shavano/Torreys

Speaker 3 of 7
Raymond M. Welsh, University of Massachusetts Medical School, USA
Cross-Reactive Pathogenic Epitopes and Vaccine Design

Thursday, January 24 | 8:00AM - 11:15AM
T Cell Memory
Room: Shavano/Torreys

Speaker 4 of 7
Donna L. Farber, Columbia University Medical Center, USA
Memory CD4 T Cell-Mediated Protection and Immunopathology in Influenza Infection

Thursday, January 24 | 8:00AM - 11:15AM
T Cell Memory
Room: Shavano/Torreys

Speaker 5 of 7
Leo Lefrançois, University of Connecticut Health Center, USA
Memory T Cell Development in vivo

Thursday, January 24 | 8:00AM - 11:15AM
T Cell Memory
Room: Shavano/Torreys

Speaker 6 of 7
Joseph D. Miller, Centers for Disease Control, USA
Short Talk: Using the Smallpox Vaccines to Study Human Effector and Memory CD8 T Cell Responses to Acute Viral Infection

Thursday, January 24 | 8:00AM - 11:15AM
T Cell Memory
Room: Shavano/Torreys

Speaker 7 of 7
Janko Nikolich-Zugich, University of Arizona College of Medicine, USA
Short Talk: Immunological Basis of Age-Related Vulnerability to West Nile Virus

Thursday, January 24 | 9:20AM - 9:40AM
Coffee Break
Room: Shavano Peak Foyer


Thursday, January 24 | 2:30PM - 4:30PM
Workshop 2: Anti-Viral Drug Discovery/Therapeutics
Room: Shavano

Speaker 1 of 2
* Barney S. Graham, NIAID, National Institutes of Health, USA

Thursday, January 24 | 2:30PM - 4:30PM
Workshop 2: Anti-Viral Drug Discovery/Therapeutics
Room: Shavano

Speaker 2 of 2
* Robert L. Coffman, Dynavax Technologies, USA

Thursday, January 24 | 2:30PM - 3:30PM
2A: Vaccines
Room: Shavano

Speaker 1 of 4
Shih-Wen Lin, National Cancer Institute, National Institutes of Health, USA
Recombinant Adeno-Associated Virus (AAV) Vectors Induce Functionally Impaired Transgene Product-Specific CD8+ T Cells

Thursday, January 24 | 2:30PM - 3:30PM
2A: Vaccines
Room: Shavano

Speaker 2 of 4
Julie Ledgerwood, NIAID, National Institutes of Health, USA
DNA Vaccines Developed for Emerging Infectious Diseases Induce Neutralizing Antibody and Cellular Immune Responses in Healthy Adults.

Thursday, January 24 | 2:30PM - 3:30PM
2A: Vaccines
Room: Shavano

Speaker 3 of 4
Corey D. Smith, Queensland Institute of Medical Research, Australia
Development of an EBV-Specific Polyepitope Based Vaccine for the Treatment of Hodgkin’s Lymphoma and Nasopharyngeal Carcinoma

Thursday, January 24 | 2:30PM - 3:30PM
2A: Vaccines
Room: Shavano

Speaker 4 of 4
Krystle N. Agans, Battelle Memorial Institute, USA
A New Adjuvanted Low-Dose Candidate Pandemic Influenza A(H5N1) Vaccine Protect Ferrets Against Homologous Clade 1 Viral Challenge and Induces Clade 2 Cross-Reactive Antibodies

Thursday, January 24 | 2:30PM - 4:30PM
Workshop 3: Antigen Presentation, Memory & Pathogenesis
Room: Torreys

Speaker 1 of 2
* Kevin L. Legge, University of Iowa Carver College of Medicine, USA

Thursday, January 24 | 2:30PM - 4:30PM
Workshop 3: Antigen Presentation, Memory & Pathogenesis
Room: Torreys

Speaker 2 of 2
* Liisa K. Selin, University of Massachusetts Medical School, USA

Thursday, January 24 | 2:30PM - 3:30PM
3A: Antigen Presentation & Lymphocyte Activation
Room: Torreys

Speaker 1 of 4
Eric F. Tewalt, University of Virginia, USA
Poxvirus-Mediated Blockade of MHC Class I-, but not MHC Class II-Restricted Presentation of Peptides Derived from Exogenous Proteins

Thursday, January 24 | 2:30PM - 3:30PM
3A: Antigen Presentation & Lymphocyte Activation
Room: Torreys

Speaker 2 of 4
Laura K. Mackay, University of Melbourne, Australia
Antigen Processing and Presentation for CD8+ and CD4+ T Cell Recognition: Newly Synthesised Versus Stable Proteins

Thursday, January 24 | 2:30PM - 3:30PM
3A: Antigen Presentation & Lymphocyte Activation
Room: Torreys

Speaker 3 of 4
Taeg S. Kim, Bristol-Myers Squibb, USA
An Airway Mucosal CD103+ dendritic Cell Subset is Specialized for Priming Influenza Virus-Specific Cytotoxic CD8+ T Cells

Thursday, January 24 | 2:30PM - 3:30PM
3A: Antigen Presentation & Lymphocyte Activation
Room: Torreys

Speaker 4 of 4
Jennifer Bassett, McMaster University, Canada
Long-Term, Low-Level Antigen Presentation Following Adenovirus Immunization Evokes a Sustained Effector/Effector Memory CD8+ T Cell Response that is Maintained by Radioresistant Antigen Presenting Cells

Thursday, January 24 | 3:30PM - 4:30PM
3B: Immunodominance, Memory and Pathogenesis
Room: Torreys

Speaker 1 of 4
Paul G. Thomas, St. Jude Children's Research Hospital, USA
CD8 T Cell Epitope Recognition: Broad Detection through a Narrow Window

Thursday, January 24 | 3:30PM - 4:30PM
3B: Immunodominance, Memory and Pathogenesis
Room: Torreys

Speaker 2 of 4
Shawn D. Blackburn, Wistar Institute, USA
Selective Expansion of a Subset of Exhausted CD8 T cells with áPD-L1 Blockade.

Thursday, January 24 | 3:30PM - 4:30PM
3B: Immunodominance, Memory and Pathogenesis
Room: Torreys

Speaker 3 of 4
Eric J. Yager, Albany Medical College, USA
Naïve Precursor T Cell Frequencies Impact Cellular Responses to Influenza Virus Infection in Aged Mice

Thursday, January 24 | 3:30PM - 4:30PM
3B: Immunodominance, Memory and Pathogenesis
Room: Torreys

Speaker 4 of 4
Nuray Aslan, University of Massachusetts Medical School, USA
Expansion of Influenza M1-specific Memory cells Cross-Reactive with two Epstein-Barr virus (EBV) Lytic Epitopes Correlate with Severity of EBV-Induced Infectious Mononucleosis

Thursday, January 24 | 3:30PM - 4:30PM
2B: Therapeutics
Room: Shavano

Speaker 1 of 4
Sharvan Sehrawat, University of Tennessee, USA
FTY720 Treatment Effectively Induces Antigen-Specific Foxp3+ Regulatory T cells: An Additional Mechanism of Immunosuppression?

Thursday, January 24 | 3:30PM - 4:30PM
2B: Therapeutics
Room: Shavano

Speaker 2 of 4
Elizabeth J. Ryan, University College Dublin, Ireland
GM-CSF may Modulate the Response to IFN-Alpha in Chronic Hepatitis C Virus (HCV) Infection

Thursday, January 24 | 3:30PM - 4:30PM
2B: Therapeutics
Room: Shavano

Speaker 3 of 4
Aurelia A. Haller, GlobeImmune Inc., USA
Therapeutic and Prophylactic Viral Immunity in Animals and Humans

Thursday, January 24 | 3:30PM - 4:30PM
2B: Therapeutics
Room: Shavano

Speaker 4 of 4
Florian Full, University Hospital Erlangen, Germany
Cytomegalovirus Specific T Cells Suitable for Adoptive Transfer: a new Approach Using CMV Specific Recombinant Immunoreceptors

Thursday, January 24 | 4:30PM - 5:00PM
Coffee Available
Room: Shavano Peak Foyer


Thursday, January 24 | 5:00PM - 7:00PM
Vaccines and Therapeutic Interventions
Room: Shavano/Torreys

Speaker 1 of 5
* Jack R. Bennink, NIAID, National Institutes of Health, USA

Thursday, January 24 | 5:00PM - 7:00PM
Vaccines and Therapeutic Interventions
Room: Shavano/Torreys

Speaker 2 of 5
Robert L. Coffman, Dynavax Technologies, USA
Development of a Hepatitis B Vaccine Using an Immunostimulatory Oligodeoxynucleotide Adjuvant

Thursday, January 24 | 5:00PM - 7:00PM
Vaccines and Therapeutic Interventions
Room: Shavano/Torreys

Speaker 3 of 5
Suzanne L. Epstein, Center for Biologics Evaluation and Research, FDA, USA
Short Talk: Comparison of Cold-Adapted and DNA Prime-Adenovirus Boost Vaccines for Induction of Heterosubtypic Immunity to Influenza A Virus

Thursday, January 24 | 5:00PM - 7:00PM
Vaccines and Therapeutic Interventions
Room: Shavano/Torreys

Speaker 4 of 5
John T. Harty, University of Iowa, USA
Regulating the CD8 T Cell Response to Infection and Vaccination

Thursday, January 24 | 5:00PM - 7:00PM
Vaccines and Therapeutic Interventions
Room: Shavano/Torreys

Speaker 5 of 5
Cliona M. Rooney, Baylor College of Medicine, USA
Development of T Cell Immunotherapies for Post-Transplant Viral Infections

Thursday, January 24 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Crestone/Red Cloud


Thursday, January 24 | 8:00PM - 11:00PM
Entertainment
Room: Crestone/Red Cloud


Thursday, January 24 | 8:00PM - 11:00PM
Cash Bar
Room: Crestone/Red Cloud


Friday, January 25 | 10:25AM - 10:25AM
Departure


*Session Chair.